Lightening strikes ! -- mid-sized Japanese pharma makes deal with biotech company !

---

If you have not seen many deals the past 3+ years between American or European biotech companies and risk-averse mid-sized Japanese pharma companies ? -- then me neither.  Here is one below.

I hear many such deals are unannounced, but most biotechs worldwide need/want an announcement as validation for fund-raising purposes.  So I really doubt the size of this "unannounced" underground Japanese deal market.  And it's certainly not something any biz dev professional should tell his peers & board members really exists.  It will just raise their expectations unduly.

Your thoughts ?

Now, let's cut to the news:


"Mitsubishi Tanabe Pharma taps Synageva for orphan disease R&D"

September 2, 2011 -- FierceBiotech.com

"Rare disease know-how remains a hot commodity.  Aiming to gain access to orphan disease and protein drug-making expertise, Mitsubishi Tanabe Pharma has struck an R&D deal with Synageva BioPharma. Lexington, MA-based Synageva, a rare disease drug developer, will pocket $3 million upfront in addition to unspecified research dollars from the Japanese drugmaker.

Using Synageva's tech for expressing therapeutic proteins, the collaborators plan to focus their research on a novel drug for treating an undisclosed orphan disease, according to a statement.  The target apparently won't be one Synageva is pursuing in its own pipeline, which includes its lead enzyme replacement therapy SBC-102 for LAL Deficiency."

...

http://www.fiercebiotech.com/story/mitsubishi-tanabe-pharma-taps-synageva-orphan-disease-rd/2011-09-02

The original release:

http://www.fiercebiotech.com/press-releases/synageva-biopharma-corp-enters-development-collaboration-mitsubishi-tanabe--0

http://www.mt-pharma.co.jp/e

----------

POSTED 05 Sept 2011 by:

David A. Palella
BIOSCIENCE VENTURES Inc.
San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog:  http://biobizdev.blogspot.com


& Group Founder:

Japan Biotech/Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Biotech / Pharma Business Development, Licensing & Dealmaking
http://www.linkedin.com/e/-ubgx8c-gp40f4dt-22/vgh/3964633/

Biofuels & Sustainable Chemicals Networking Group
http://www.linkedin.com/e/vgh/3891375/

& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448


------------